LEZACK ADAM sold 6.8% of their position (2K shares) of BETA BIONICS, INC. on the open market
Open‑market sale worth $21.1K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 5/26/2026ACC: 0002048466-26-000003
+14.97K
Net shares
Net buyer
$21.1K
Total sold
2
Open market trades
0B · 2S
3
Total transactions
16.96K acquired · 2K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−1K
Price / share
$9.95
Trade value
$9.95K
% of position
8.0%
5/21/2026
12.43K→11.43K
Common Stock
Direct
Shares
+16.96K
Price / share
—
Trade value
—
% of position
148.4%
5/21/2026
11.43K→28.40K
Comon Stock
Direct
Shares
−998.00
Price / share
$11.21
Trade value
$11.19K
% of position
3.5%
5/22/2026
28.40K→27.40K
Total
Net shares
+14.97K
Net value
-$21.14K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/21/2026 | S · Sale | −1K | $9.95 | $9.95K | 8.0% | 12.43K | 11.43K |
| Common Stock Direct | 5/21/2026 | A · Award | +16.96K | — | — | 148.4% | 11.43K | 28.40K |
| Comon Stock Direct | 5/22/2026 | S · Sale | −998.00 | $11.21 | $11.19K | 3.5% | 28.40K | 27.40K |
| Total | +14.97K | -$21.14K | ||||||
Derivative Transactions0
No derivative transactions reported